(Q36958999)

17 August 2017

1 reference

title

Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections (English)

1 reference

17 August 2017

David M Rothstein

1

1 reference

17 August 2017

John van Duzer

series ordinal

2

1 reference

17 August 2017

Andrew Sternlicht

series ordinal

3

1 reference

17 August 2017

Steven C Gilman

series ordinal

4

1 reference

17 August 2017

publication date

1 October 2007

1 reference

Archiv der Pharmazie - Chemistry in Life Sciences

17 August 2017

published in

1 reference

17 August 2017

volume

340

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

517-529

1 reference

Medical treatment of peripheral arterial disease: a comprehensive review

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Enhanced activity of rifalazil in combination with levofloxacin, linezolid, or mupirocin against Staphylococcus aureus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.200700080

21 January 2018

Identifiers

DOI

10.1002/ARDP.200700080

1 reference

17 August 2017

1 reference